Amprius Technologies reports today carrying one of the heavier short positions in its peer group — yet the analyst consensus, the borrow market, and recent price action are all pointing in the opposite direction.
Short interest is the defining tension in this setup. Bears hold 21.3% of the free float short, a position that has grown roughly 20% over the past month even as the stock ripped 18% higher on the week and 6.8% in yesterday's session alone. The borrow market, however, offers little urgency to cover: availability runs at 412% — meaning for every share currently lent out, more than four remain available — and cost to borrow is a negligible 0.42%, even after a 33% rise on the week. That combination, heavy short positioning but a relaxed lending market, tells a story of conviction rather than a squeeze. The ORTEX short score sits at 59.2, reflecting elevated but not extreme pressure.
Options traders are not endorsing the bearish view. The put/call ratio is running at 0.69, almost exactly in line with its 20-day average of 0.68 and nowhere near the 52-week defensive extreme of 0.73 hit in late July. With a z-score close to zero, there is no detectable options-market anxiety heading into the print — a contrast with the short sellers' elevated commitment.
The bull case leans heavily on commercial traction. Amprius shipped to 93 customers last quarter, including 43 new clients, and management projects margins expanding from 14.7% in 2026 to 25–27% by 2028. The analyst community is entirely in the buy camp — nine buy ratings, zero holds or sells, with Jones Trading initiating coverage in July at a $30 target. That consensus points to roughly 113% upside from the current $10.81 close, though it is worth noting targets range widely and the stock has already pulled back about 13% from its one-month high. Bears counter that the company has not turned a profit: the most recent quarterly net loss was $6.4 million, and the EV/EBITDA multiple is stretched above 83x. With EPS surprise scoring in the 93rd percentile by ORTEX factor rankings — suggesting a history of beating estimates — the profitability picture is the key line bears need to cross-examine.
Institutional flows add a layer of nuance. BlackRock added 1.5 million shares last quarter, and T. Rowe Price initiated a position of nearly 1.9 million shares in the most recent period. That points to growing index and active interest. Against that, insiders have been consistent sellers: the Chairman sold over $2.2 million worth of stock between late May and mid-June, and the CEO sold shares in early June as well — net insider activity across 90 days runs to a positive figure in share terms, but that reflects earlier grant-related flows rather than open-market buying.
Today's print tests whether Amprius can show enough momentum in customer additions and margin progression to justify both the analyst optimism and the institutional accumulation — while simultaneously challenging the short sellers who have doubled down through the recent rally.
See the live data behind this article on ORTEX.
Open AMPX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
